Back
ESC Professional Premium Access

Impact of triple vasodilator therapy on prognosis stratification of pulmonary arterial hypertension associated with congenital heart disease

Session: Risk assessment in pulmonary hypertension: still a hot topic
Topic: Pharmacotherapy
Speaker: Doctor R. Luna (Barcelona, ES)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Raquel Luna

Hospital Clinic of Barcelona, Barcelona (Spain)
0 follower

6 more presentations in this session

Comprehensive risk assessment in patients with pulmonary arterial hypertension referred for lung transplantation: a single-center experience

Speaker: Doctor S. Ishii (Tokyo, JP)

Access
Abstract
Slides
Video
Thumbnail

REVEAL Score performance in patients with WHO Group 2 pulmonary hypertension

Speaker: Doctor D. Sharp Dimitri (Cincinnati, US)

Access
Abstract
Slides
Video
Thumbnail

Analysis of prognostic predictors and differences between subgroups of pulmonary arterial hypertension associated with portal hypertension and HIV infection

Speaker: Doctor R. Bertozzi (Bologna, IT)

Access
Abstract
Slides
Video
Thumbnail

Applicability of the 3-Strata ESC/ERS risk model at baseline in pulmonary veno-occlusive disease

Speaker: Doctor A. Cruz Utrilla (Madrid, ES)

Access
Abstract
Slides
Video
Thumbnail

Phenotype and outcome correlates of high dose loop diuretics in type 1 pulmonary hypertension

Speaker: Doctor D. Barbisan (Treviso, IT)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Risk assessment in pulmonary hypertension: still a hot topic

Speakers: Doctor R. Luna, Doctor S. Ishii, Doctor D. Sharp Dimitri, Doctor R. Bertozzi, Doctor A. Cruz Utrilla...
Access
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb